Sixfold Bio, England, United Kingdom
Dr Alice Ghidini is the Lead of the RNA Structure and Characterization team in Sixfold Bioscience Ltd, a biotech start-up located in the Imperial College I-HUB. In her current role she has been awarded the Future leader fellowship by the UK Research and Innovation.
She has a broad background in RNA-therapeutics technology gained during her doctoral and postdoctoral studies in the labs of Prof. Stromberg, Prof. Dervan and Prof. Hall. In 2021 she joined the Oligonucleotide platform of AstraZeneca as Assistant Principal Scientist in the Biophysics department, where she studied the influence of oligonucleotide/proteins binding on their toxicity and potency.
She accumulated expertise on the interaction between oligonucleotides and proteins/RNA targets. She has been working on the development of innovative technologies such as RNA-based artificial enzymes, oligo triplexes and oligonucleotide-based PROTACs and structural/biophysical/biochemical analytical assays and analysed the interactions between RNA and other biological components.
Disclosure information not submitted.
Revolutionizing RNA Delivery: Harnessing the Body's Evolved Transport Pathways
Wednesday, February 7, 2024
9:30 AM – 10:00 AM EST